Nutex Health (NUTX) 10-Q 2016 Q2 Quarterly report

Exhibit 32.1

WRITTEN STATEMENT OF THE CHIEF EXECUTIVE OFFICER

Pursuant to 18 U.S.C. Section 1350

As adopted pursuant to section 906 of the Sarbanes-Oxley act of 2002

Solely for the purposes of complying with 18 U.S.C. s.1350 as adopted pursuant to section 906

of the Sarbanes-Oxley act of 2002, I, the undersigned Chief Executive Officer of iGambit Inc.

(the “Company”), hereby certify, based on my knowledge, that the Quarterly Report on Form 10-

Q of the Company for the quarter ended June 30, 2013, (the “Report”) fully complies with the

requirements of Section 13(a) of the Securities Exchange Act of 1934 and that information

contained in the Report fairly presents, in all material respects, the financial condition and results

of operations of the Company.

August 22, 2016

/s/ Rory T. Welch

Chief Executive Officer

1